Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced commercial availability of the company’s new solution for interventional rooms, Ambient Experience with FlexVision display, which will be showcased at the American College of Cardiology’s 71st Annual Scientific Session & Expo (ACC 2022), April 2-4, Washington, D.C., USA. Connecting to Philips Image Guided Therapy System - Azurion, it uses the system’s large display to offer patients a calming multi-sensory experience while staff prepare them for their procedure, prior to the display being used for the actual intervention. It also allows patients and interventional team members to adapt the room’s ambient lighting and sound to add to the overall feeling of calm, especially during the patient entry and preparation phases of procedures. Aimed at reducing patient anxiety during interventional procedures, Ambient Experience, leveraging FlexVision display, has the potential to improve the patient and staff experience, positively impact outcomes, and enhance workflows and productivity.
Anxiety in patients undergoing minimally-invasive image-guided therapy typically peaks immediately before the procedure is performed. As a result, sedative drugs and general anesthesia are commonly used in interventional rooms to ensure patients lie still during procedures. Mitigating the clinical atmosphere associated with typical interventional rooms by introducing positive elements that distract, inform, educate, and empower patients, Philips Ambient Experience aims to reduce patient anxiety to a level where interventionists can operate more productively and efficiently. For example, the solution could reduce the overall procedure time and, in some cases, reduce the costs associated with patient sedation or general anesthesia .